Pseudohypoparathyroidism laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pseudohypoparathyroidism}}
{{Pseudohypoparathyroidism}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}}{{Mazia}}


{{PleaseHelp}}


==Overview==
==Overview==
The diagnosis of pseudohypoparathyroidism is made by measurement of variations in serum [[calcium]], [[phosphorus]], [[cAMP]] and [[calcitriol]] and in urinary [[Cyclic adenosine monophosphate|cAMP]] and [[phosphorus]] excretion helps in assessment of skeletal and renal responsiveness to [[parathyroid]] hormone.


==Laboratory Findings==
==Laboratory Findings==
* [[Hypocalcemia]]
*The diagnosis of pseudohypoparathyroidism is made by measurement of variations in serum [[calcium]], [[phosphorus]], [[cAMP]] and [[calcitriol]] and in urinary [[Cyclic adenosine monophosphate|cAMP]] and [[phosphorus]] excretion helps in assessment of skeletal and renal responsiveness to [[parathyroid]] hormone.
* [[Hyperphosphatemia]]
*Laboratory findings consistent with the diagnosis of pseudohypoparathyroidism include
* Elevated [[parathyroid hormone]] ([[hyperparathyroidism]])
**[[Hypocalcemia]]
*Blood tests: Patients with pseudohypoparathyroidism may indicate signs, such as low levels of blood-[[calcium]], blood-[[magnesium]] and a high level of blood-[[phosphorus]]. The level of [[parathyroid hormone]] may ususally be normal.
**[[Hyperphosphatemia]]
*Urine calcium test: Patients with pseudohypoparathyroidism may show much higher levels of urine calcium than normal.
**Elevated serum concentration of [[parathyroid hormone]]
*[[Genetic testing]]: Genetic testing can find abnormal genes and allow the genetic diagnosis to inherit diseases like pseudohypoparathyroidism.
**Diminished urinary [[cAMP]] response after administration of the biosynthetic N-terminal fragment of [[parathyroid]] hormone
**[[Secondary hyperparathyroidism]] and [[hyperparathyroid]] bone disease due to the [[parathyroid]] hormone resistance .


*Immunoradiometric assay (IRMA) can be used to measure serum [[parathyroid]] hormone concentration.<ref name="pmid18663313">{{cite journal |vauthors=Shalitin S, Davidovits M, Lazar L, Weintrob N |title=Clinical heterogeneity of pseudohypoparathyroidism: from hyper- to hypocalcemia |journal=Horm. Res. |volume=70 |issue=3 |pages=137–44 |year=2008 |pmid=18663313 |doi=10.1159/000137658 |url=}}</ref>
*Assessment of [[thyroid function tests]], [[gonadotropin]], [[testosterone]], [[estrogen]] and insulin like growth factor will help in identification of any associated underlying hormonal dysfunction
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]

Revision as of 19:51, 28 September 2017

Pseudohypoparathyroidism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pseudohypoparathyroidism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudohypoparathyroidism laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudohypoparathyroidism laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudohypoparathyroidism laboratory findings

CDC on Pseudohypoparathyroidism laboratory findings

Pseudohypoparathyroidism laboratory findings in the news

Blogs on Pseudohypoparathyroidism laboratory findings

Directions to Hospitals Treating Pseudohypoparathyroidism

Risk calculators and risk factors for Pseudohypoparathyroidism laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]


Overview

The diagnosis of pseudohypoparathyroidism is made by measurement of variations in serum calcium, phosphorus, cAMP and calcitriol and in urinary cAMP and phosphorus excretion helps in assessment of skeletal and renal responsiveness to parathyroid hormone.

Laboratory Findings

  • Immunoradiometric assay (IRMA) can be used to measure serum parathyroid hormone concentration.[1]

References

  1. Shalitin S, Davidovits M, Lazar L, Weintrob N (2008). "Clinical heterogeneity of pseudohypoparathyroidism: from hyper- to hypocalcemia". Horm. Res. 70 (3): 137–44. doi:10.1159/000137658. PMID 18663313.


Template:WikiDoc Sources